Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
VNDA holding history
Vanda Pharmaceuticals Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VNDA overviewAll 13F holders of VNDAFull Q4 2024 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −192,884−100.0% | Sold out | Holders |
| Q3 2023 | 192,884 | $833.3K | 0.1% | +151,344+364.3% | Added | Holders |
| Q2 2023 | 41,540 | $273.7K | <0.1% | −111,844−72.9% | Reduced | Holders |
| Q1 2023 | 153,384 | $1.04M | 0.2% | +23,759+18.3% | Added | Holders |
| Q4 2022 | 129,625 | $957.9K | 0.1% | +14,274+12.4% | Added | Holders |
| Q3 2022 | 115,351 | $1.14M | 0.2% | +3,001+2.7% | Added | Holders |
| Q2 2022 | 112,350 | $1.23M | 0.2% | +71,049+172.0% | Added | Holders |
| Q1 2022 | 41,301 | $467.0K | <0.1% | +41,301 | New | Holders |